Smyth et al. use tissue microarrays from Alzheimer’s disease (AD) patient brains to show that PDGF-BB:PDGFRβ signalling components are reduced in AD. This evidence concerns the gene PDGFRB and early-onset autosomal dominant Alzheimer disease.